Clinical Research

Bial Portela & Ca S.A.

Address
A Avenida Da Siderurgia Nacional

Sponsor Overview

assignment
4
sponsored trials
science
0
molecules
location_city
2
research centres
public
2
countries
person_search
2
investigators

Specializations

Anti-infective Medicines

Clinical research activity includes amoxicillin and clavulanic acid formulations, with attention to oral tablets and suspension products used in antibacterial therapy.

  • Oral antibiotic formulations
  • Combination antibacterial products
  • Suspension and tablet presentations

The sponsor’s work in this area centers on established beta-lactam antibiotics and related fixed-combination treatments.

Pharmacokinetics and Bioequivalence

Several studies focus on comparing bioequivalence across different dose forms and strengths, reflecting interest in how products are absorbed and matched to reference medicines.

  • Comparative product performance
  • Systemic exposure assessment
  • Reference formulation matching

This area is closely tied to the development of interchangeable generic medicines for routine clinical use.

Healthy Volunteer Research

The sponsor conducts studies in healthy participants, supporting evaluation of medicine handling in individuals without active disease and enabling controlled assessment of exposure and tolerability.

  • Volunteer-based clinical studies
  • Controlled exposure evaluation
  • Safety observation in non-patient populations

This research setting is used for both oral antibiotic products and interaction-focused investigations.

Drug–Drug Interaction Studies

One area of interest involves interaction studies with compounds such as clarithromycin, midazolam, and dabigatran etexilate, indicating work in metabolic and transport-related medicine interactions.

  • Interaction with antibacterial agents
  • CYP-related investigation
  • Anticoagulant interaction assessment

These studies address how investigational compounds behave alongside established therapies in healthy adults.

Sponsored Trials

Trial Name Country Status
Bioequivalence Study of Amoxicillin and Clavulanic Acid 250 mg/62.5 mg/5 mL Oral Suspension Compared to Augmentin® Forte in Healthy Subjects Under Fed ConditionsPortugal PortugalNot Recruiting
Bioequivalence Study of Amoxicillin and Clavulanic Acid 500 mg/125 mg Film-Coated Tablets in Healthy Subjects Under Fed ConditionsPortugal PortugalNot Recruiting
Bioequivalence Study of Amoxicillin and Clavulanic Acid 875 mg/125 mg Film-Coated Tablets in Healthy Subjects Under Fed ConditionsPortugal PortugalNot Recruiting
Investigation of Pharmacokinetic Interactions Between BIA 28-6156, Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy SubjectsBelgium BelgiumNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
50%
Return partnership rate
1 of 2 sites collaborated multiple times

This sponsor has worked with 2 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Not possible to specify3 trials
    220 other sponsors
  • 2.
    Nervous System Diseases1 trial
    449 other sponsors

Partnered Research Centres

2 centres
location_city
assignment87
Blueclinical Investigacao E Desenvolvimento Em Saude Lda.
Address
Hospital Da Prelada 0 Floor And 3 rd Floor, Rua Sarmento De Beires 153, 4250-449 Porto
Learn morearrow_forward
location_city
assignment70
SGS Belgium
Address
Drie Eikenstraat 655, 2650 Edegem
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Bial Portela & Ca S.A..

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.